ProImmune - Mastering Immunity | MHC pentamers, CD1d tetramers, custom peptide synthesis, immunoassays, T cell epitope discovery, HLA tissue typing, cellular analysis, ligand binding assays, immune response

Mastering Immunity

ProImmune’s mission is to be your partner of choice for understanding and managing adaptive immune responses. Our unique innovative solutions for preclinical and clinical immunology research help you take your studies to success through responsive service and focused application support, saving you time and money and reducing risk.

Our Story     Our Clients


Request a Quote

Subscribe to Email Newsletters


USA/Canada Toll free: + 1 888 505 7765

All other countries: + 44 870 042 7279

Video Content

Mastering Immunity Conferences

Prof. Paul Moss

University of Birmingham

“Direct visualisation of antigen-specific CD4+ T cells: insights from HLA class II tetramers”

Dr. Bernard Maillère

CEA, France

“Comprehensive analysis of pre-existing T cells specific to therapeutic proteins in healthy donors”

Dr. Wei Xu

Roche Innovation Center Zurich, Switzerland

“Combination immunotherapy and vaccines in cancer”

Dr. Ethan Shevach


"Tregs -ready for the clinic?"

Dr. Timothy Hickling

Pfizer, Inc.

Contribution of ex vivo assays to immunogenicity risk assessment

Dr. Gene Olinger


“Development of a monoclonal antibody cocktail for Ebola virus therapy: convergence of plants, mice, and humans”

Prof. Herman Waldmann

University of Oxford

Tolerance can be induced in the adult immune system

Prof. David Wraith

University of Bristol

“Switching off immunity: the mechanism of antigen-specific immunotherapy”

Dr. Susan Kirshner


Therapeutic Proteins: Route of exposure and immunogenicity risk

Prof. Jean Rommelaere

DKFZ, Germany

“Use of oncolytic parvoviruses in the treatment of malignant gliomas: a viro-immunotherapeutic approach”

Watch More Content


Pro5® MHC Pentamers for T Cell detection

ProVE® Class I MHC Pentamer Libraries

New: ProT2® MHC Class II Tetramers

ProM2® MHC Class II Monomers

CD1d Tetramers for NKT Cell detection

ProMix™ Immunodominant Peptide Pools

thinkpeptides®: Custom Peptide Synthesis

Services (by application)

Immunogenicity in Drug Development


Antigen Characterization

Immune Monitoring

Services (by assay)

ProPresent® Antigen Presentation Assay

ProSentium™ Antigen Presentation Data

ProMap™ T Cell Proliferation Assays

ProScern™ DC-T Cell Proliferation Assays

MHC I Binding Assays

MHC II Binding Assays

MHC II Binding Competition Assays

Prostorm® Cytokine Release Assay

ELISPOT Assay Service

Flow Cytometry Assay Service

ProArray Ultra® Ligand Binding Assays

ProArray Ultra® B-Cell Epitope Mapping

typeHLA Tissue Typing Service

Custom Methods: The Special Assay Service



Latest News

Join us for our next Mastering Immunity 6 Conference in Boston on 11 and 12 September 2017

Opportunities in Cancer Immunotherapy: download our new guide showing you how to capitalize on them with our products and services


Latest customer publications

Pro5® MHC Pentamers used in NIH study to investigate fatal brain stem pathology caused by antigen-specific CD8+ T cells in Malaria

Figure from: Swanson P.A. et al., PLOS Pathogens (2016) CD8+ T Cells Induce Fatal Brainstem Pathology during Cerebral Malaria via Luminal Antigen-Specific Engagement of Brain Vasculature





Product Information Sheets

Free Resources & Downloads

Peptides Information Poster

Peptides eBook

Pentamer Catalog Pentamer Handbook Cancer Immunotherapy
Pro5® Pentamer catalog Pro5® Pentamer Handbook Opportunities in Cancer Immunotherapy